Enhanced elimination of oxidized guanine nucleotides inhibits oncogenic ras-induced dna damage and premature senescence

Enhanced elimination of oxidized guanine nucleotides inhibits oncogenic ras-induced dna damage and premature senescence

Play all audios:

Loading...

ABSTRACT Approximately 20% of tumors contain activating mutations in the RAS family of oncogenes. As tumors progress to higher grades of malignancy, the expression of oncogenic RAS has been


reported to increase, leading to an oncogene-induced senescence (OIS) response. Evasion of this senescence barrier is a hallmark of advanced tumors indicating that OIS serves a critical


tumor-suppressive function. Induction of OIS has been attributed to either RAS-mediated production of reactive oxygen species (ROS) or to induction of a DNA damage response (DDR). However,


functional links between these two processes in triggering the senescent phenotype have not been explicitly described. Our previous work has shown that, in cultured untransformed cells,


preventing elimination of oxidized guanine deoxyribonucleotides, which was achieved by suppressing expression of the cellular 8-oxo-dGTPase, human MutT homolog 1 (MTH1), sufficed to induce a


DDR as well as premature senescence. Here, we demonstrate that overexpression of MTH1 can prevent the oncogenic H-RAS-induced DDR and attendant premature senescence, although it does not


affect the observed elevation in ROS levels produced by RAS oncoprotein expression. Conversely, we find that loss of MTH1 preferentially induces an _in vitro_ proliferation defect in


tumorigenic cells overexpressing oncogenic RAS. These results indicate that the guanine nucleotide pool is a critical target for intracellular ROS produced by oncogenic RAS and that


RAS-transformed cells require robust MTH1 expression to proliferate. Access through your institution Buy or subscribe This is a preview of subscription content, access via your institution


ACCESS OPTIONS Access through your institution Subscribe to this journal Receive 50 print issues and online access $259.00 per year only $5.18 per issue Learn more Buy this article *


Purchase on SpringerLink * Instant access to full article PDF Buy now Prices may be subject to local taxes which are calculated during checkout ADDITIONAL ACCESS OPTIONS: * Log in * Learn


about institutional subscriptions * Read our FAQs * Contact customer support SIMILAR CONTENT BEING VIEWED BY OTHERS PPM1D ACTIVITY PROMOTES CELLULAR TRANSFORMATION BY PREVENTING SENESCENCE


AND CELL DEATH Article Open access 05 September 2024 ONCOGENIC RAS SENSITIZES CELLS TO DRUG-INDUCED REPLICATION STRESS VIA TRANSCRIPTIONAL SILENCING OF P53 Article Open access 07 April 2022


ZNF768 LINKS ONCOGENIC RAS TO CELLULAR SENESCENCE Article Open access 17 August 2021 REFERENCES * Algarra I, Perez M, Serrano MJ, Garrido F, Gaforio JJ . (1998). c-K-ras overexpression is


characteristic for metastases derived from a methylcholanthrene-induced fibrosarcoma. _Invasion Metastasis_ 18: 261–270. Article  CAS  Google Scholar  * Bartkova J, Rezaei N, Liontos M,


Karakaidos P, Kletsas D, Issaeva N _et al_. (2006). Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. _Nature_ 444: 633–637. Article  CAS 


Google Scholar  * Benanti JA, Galloway DA . (2004). Normal human fibroblasts are resistant to RAS-induced senescence. _Mol Cell Biol_ 24: 2842–2852. Article  CAS  Google Scholar  * Buchholz


M, Braun M, Heidenblut A, Kestler HA, Kloppel G, Schmiegel W _et al_. (2005). Transcriptome analysis of microdissected pancreatic intraepithelial neoplastic lesions. _Oncogene_ 24:


6626–6636. Article  CAS  Google Scholar  * Di Micco R, Fumagalli M, Cicalese A, Piccinin S, Gasparini P, Luise C _et al_. (2006). Oncogene-induced senescence is a DNA damage response


triggered by DNA hyper-replication. _Nature_ 444: 638–642. Article  CAS  Google Scholar  * Dimri G, Lee X, Basile G, Acosta M, Scott G, Roskelley C _et al_. (1995). A biomarker that


identifies senescent human cells in culture and in aging skin _in vivo_. _Proc Natl Acad Sci USA_ 92: 9363–9367. Article  CAS  Google Scholar  * Elenbaas B, Spirio L, Koerner F, Fleming MD,


Zimonjic DB, Donaher JL _et al_. (2001). Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells. _Genes Dev_ 15: 50–65. Article  CAS  Google


Scholar  * Gackowski D, Kruszewski M, Bartlomiejczyk T, Jawien A, Ciecierski M, Olinski R . (2002). The level of 8-oxo-7,8-dihydro-2′-deoxyguanosine is positively correlated with the size of


the labile iron pool in human lymphocytes. _J Biol Inorg Chem_ 7: 548–550. Article  CAS  Google Scholar  * Garber ME, Troyanskaya OG, Schluens K, Petersen S, Thaesler Z, Pacyna-Gengelbach M


_et al_. (2001). Diversity of gene expression in adenocarcinoma of the lung. _Proc Natl Acad Sci USA_ 98: 13784–13789. Article  CAS  Google Scholar  * Haghdoost S, Sjolander L, Czene S,


Harms-Ringdahl M . (2006). The nucleotide pool is a significant target for oxidative stress. _Free Radic Biol Med_ 41: 620–626. Article  CAS  Google Scholar  * Irani K, Xia Y, Zweier JL,


Sollott SJ, Der CJ, Fearon ER _et al_. (1997). Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts. _Science_ 275: 1649–1652. Article  CAS  Google Scholar  * Kasai H,


Nishimura S . (1984). Hydroxylation of deoxyguanosine at the C-8 position by ascorbic acid and other reducing agents. _Nucleic Acids Res_ 12: 2137–2145. Article  CAS  Google Scholar  * Kasid


A LM, Papageorge AG, Lowy DR, Gelmann EP . (1985). Transfection of v-rasH DNA into MCF-7 human breast cancer cells bypasses dependence on estrogen for tumorigenicity. _Science_ 228:


725–728. Article  CAS  Google Scholar  * Kawanishi S, Hiraku Y, Oikawa S . (2001). Mechanism of guanine-specific DNA damage by oxidative stress and its role in carcinogenesis and aging.


_Mutat Res_ 488: 65–76. Article  CAS  Google Scholar  * Kruszewski M . (2003). Labile iron pool: the main determinant of cellular response to oxidative stress. _Mutat Res_ 531: 81–92.


Article  CAS  Google Scholar  * Lee AC, Fenster BE, Ito H, Takeda K, Bae NS, Hirai T _et al_. (1999). Ras proteins induce senescence by altering the intracellular levels of reactive oxygen


species. _J Biol Chem_ 274: 7936–7940. Article  CAS  Google Scholar  * Mallette FA, Gaumont-Leclerc M-F, Ferbeyre G . (2007). The DNA damage signaling pathway is a critical mediator of


oncogene-induced senescence. _Genes Dev_ 21: 43–48. Article  CAS  Google Scholar  * Mitsushita J, Lambeth JD, Kamata T . (2004). The superoxide-generating oxidase Nox1 is functionally


required for Ras oncogene transformation. _Cancer Res_ 64: 3580–3585. Article  CAS  Google Scholar  * Moiseeva O, Bourdeau V, Roux A, Deschenes-Simard X, Ferbeyre G . (2009). Mitochondrial


dysfunction contributes to oncogene-induced senescence. _Mol Cell Biol_ 29: 4495–4507. Article  CAS  Google Scholar  * Nakabeppu Y . (2001). Molecular genetics and structural biology of


human MutT homolog, MTH1. _Mutat Res_ 477: 59–70. Article  CAS  Google Scholar  * Quintanilla M, Brown K, Ramsden M, Balmain A . (1986). Carcinogen-specific mutation and amplification of


Ha-ras during mouse skin carcinogenesis. _Nature_ 322: 78–80. Article  CAS  Google Scholar  * Radisky DC, Levy DD, Littlepage LE, Liu H, Nelson CM, Fata JE _et al_. (2005). Rac1b and


reactive oxygen species mediate MMP-3-induced EMT and genomic instability. _Nature_ 436: 123–127. Article  CAS  Google Scholar  * Rai P, Onder TT, Young JJ, McFaline JL, Pang B, Dedon PC _et


al_. (2009). Continuous elimination of oxidized nucleotides is necessary to prevent rapid onset of cellular senescence. _Proc Natl Acad Sci USA_ 106: 169–174. Article  Google Scholar  *


Sarkisian CJ, Keister BA, Stairs DB, Boxer RB, Moody SE, Chodosh LA . (2007). Dose-dependent oncogene-induced senescence _in vivo_ and its evasion during mammary tumorigenesis. _Nat Cell


Biol_ 9: 493–505. CAS  PubMed  Google Scholar  * Serra V, von Zglinicki T, Lorenz M, Saretzki G . (2003). Extracellular superoxide dismutase is a major antioxidant in human fibroblasts and


slows telomere shortening. _J Biol Chem_ 278: 6824–6830. Article  CAS  Google Scholar  * Stewart SA, Dykxhoorn DM, Palliser D, Mizuno H, Yu EY, An DS _et al_. (2003). Lentivirus-delivered


stable gene silencing by RNAi in primary cells. _RNA_ 9: 493–501. Article  CAS  Google Scholar  * Struthers L, Patel R, Clark J, Thomas S . (1998). Direct detection of 8-oxodeoxyguanosine


and 8-oxoguanine by avidin and its analogues. _Anal Biochem_ 255: 20–31. Article  CAS  Google Scholar  * Trachootham D, Alexandre J, Huang P . (2009). Targeting cancer cells by ROS-mediated


mechanisms: a radical therapeutic approach? _Nat Rev Drug Discov_ 8: 579–591. Article  CAS  Google Scholar  * Trachootham D, Zhou Y, Zhang H, Demizu Y, Chen Z, Pelicano H _et al_. (2006).


Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by [beta]-phenylethyl isothiocyanate. _Cancer Cell_ 10: 241–252. Article  CAS  Google Scholar  * Yagoda


N, von Rechenberg M, Zaganjor E, Bauer AJ, Yang WS, Fridman DJ _et al_. (2007). RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels. _Nature_ 447: 865–869.


Article  CAS  Google Scholar  * Yang WS, Stockwell BR . (2008). Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring


cancer cells. _Chem Biol_ 15: 234–245. Article  CAS  Google Scholar  * Yoon S-H, Hyun J-W, Choi J, Choi E-Y, Kim H-J, Lee S-J _et al_. (2005). _in vitro_ evidence for the recognition of


8-oxoGTP by Ras, a small GTP-binding protein. _Biochem Biophys Res Commun_ 327: 342–348. Article  CAS  Google Scholar  Download references ACKNOWLEDGEMENTS We are grateful to Anisleidys


Munoz for experimental assistance. We thank Dr Carlos Perez-Stable and Dr Ramiro Verdun for helpful comments on this manuscript. RAW is a Professor at American Cancer Society Research and at


Daniel K Ludwig Cancer Research. This work was supported by a Leukemia and Lymphoma Society Postdoctoral fellowship and a James and Esther King Florida Biomedical Research Program New


Investigator grant (to PR), a Howard Hughes Medical Institute summer undergraduate fellowship (to JJY) and grants from the Ellison Medical Foundation for Aging Research, The Ludwig Center


for Molecular Oncology and the Breast Cancer Research Fund (to RAW). AUTHOR INFORMATION Author notes * J J Young Present address: 5Current address: Department of Medicine, University of


California, San Francisco, CA, USA., * T T Onder Present address: 6Current address: Children's Hospital Boston, Harvard Medical School, Boston, MA, USA., AUTHORS AND AFFILIATIONS *


Division of Gerontology and Geriatric Medicine, Department of Medicine, University of Miami, Miller School of Medicine, Miami, FL, USA P Rai, D G A Burton & M G Giribaldi * Whitehead


Institute for Biomedical Research, Cambridge, MA, USA J J Young, T T Onder & R A Weinberg * Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA J J Young, T


T Onder & R A Weinberg * Ludwig Center for Molecular Oncology, Cambridge, MA, USA R A Weinberg Authors * P Rai View author publications You can also search for this author inPubMed 


Google Scholar * J J Young View author publications You can also search for this author inPubMed Google Scholar * D G A Burton View author publications You can also search for this author


inPubMed Google Scholar * M G Giribaldi View author publications You can also search for this author inPubMed Google Scholar * T T Onder View author publications You can also search for this


author inPubMed Google Scholar * R A Weinberg View author publications You can also search for this author inPubMed Google Scholar CORRESPONDING AUTHOR Correspondence to P Rai. ETHICS


DECLARATIONS COMPETING INTERESTS The authors declare no conflict of interest. ADDITIONAL INFORMATION Supplementary Information accompanies the paper on the Oncogene website SUPPLEMENTARY


INFORMATION SUPPLEMENTARY FIGURE S1 (PDF 784 KB) SUPPLEMENTARY FIGURE S2 (PDF 3478 KB) SUPPLEMENTARY FIGURE S3 (PDF 1837 KB) SUPPLEMENTARY FIGURE S4 (PDF 1450 KB) SUPPLEMENTARY FIGURE


LEGENDS (DOC 93 KB) RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Rai, P., Young, J., Burton, D. _et al._ Enhanced elimination of oxidized guanine


nucleotides inhibits oncogenic RAS-induced DNA damage and premature senescence. _Oncogene_ 30, 1489–1496 (2011). https://doi.org/10.1038/onc.2010.520 Download citation * Received: 21 March


2010 * Revised: 04 October 2010 * Accepted: 05 October 2010 * Published: 15 November 2010 * Issue Date: 24 March 2011 * DOI: https://doi.org/10.1038/onc.2010.520 SHARE THIS ARTICLE Anyone


you share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy to clipboard Provided by the


Springer Nature SharedIt content-sharing initiative KEYWORDS * cellular senescence * DNA damage * oxidative stress * 8-oxoguanine * MTH1 * RAS oncogene